Evidence map›Paper›PMID 36845226›Full record

ArticleThe Pan African medical journal2022

[Moderate bilateral carpal tunnel syndrome improved by median nerve neurodynamic mobilization: a case report].

Hassan Beddaa, Bouchra Kably, Basma Marzouk, Youness Azemmour, Ismail Bouzekraoui Alaoui, Nazha Birouk

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hassan BeddaaLaboratoire de Biostatistiques de Recherche Clinique et épidémiologique, Université Mohamed V de Rabat, Rabat, Maroc.
Bouchra KablyService de Neurophysiologie Clinique, Hôpital de Spécialités, Centre Hospitalier Universitaire, Université Mohamed V de Rabat, Rabat, Maroc.
Basma MarzoukService de Neurophysiologie Clinique, Hôpital de Spécialités, Centre Hospitalier Universitaire, Université Mohamed V de Rabat, Rabat, Maroc.
Youness AzemmourLaboratoire de Biostatistiques de Recherche Clinique et épidémiologique, Université Mohamed V de Rabat, Rabat, Maroc.
Ismail Bouzekraoui AlaouiComité National Olympique Marocain, Rabat, Maroc.
Nazha BiroukService de Neurophysiologie Clinique, Hôpital de Spécialités, Centre Hospitalier Universitaire, Université Mohamed V de Rabat, Rabat, Maroc.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carpal tunnel syndrome is the most common neuropathy affecting the upper limb. Several therapeutic approaches are used to treat this syndrome, including conservative treatment, often used as the first line treatment. We here report the case of a 61-year-old female patient, presenting to the Department of Clinical Neurophysiology of the Specialty Hospital, Rabat, with moderate and bilateral carpal tunnel syndrome with sensory loss confirmed by electroneuromyography (ENMG). Manual therapy, including bilateral median nerve neurodynamic mobilization, was performed. Patient´s outcome was marked by disappearance of nocturnal numbness and follow up ENMG showed a marked improvement in nerve conduction parameters. Based on this positive result, neurodynamic mobilization of the median nerve may be considered as a possible approach for the conservative treatment of carpal tunnel syndrome.

Indexed as

Carpal Tunnel SyndromeMusculoskeletal ManipulationsConservative TreatmentFemaleHumansMedian NerveMiddle AgedPain Measurementcarpal tunnel syndromecase reportelectroneuromyogramneurodynamic mobilization techniquesPain

Identifiers

PMID36845226
PMCPMC9949299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.